skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Pitchaiah Mandava, M.D., Ph.D.

Associate Professor of Neurology

Clinical Service Area

Neurology

Medical School

M.D., University of Texas, Medical Branch at Galveston, Texas

Graduate School

Ph.D., University of Texas, Dallas, Texas

Contact Information

Pitchaiah Mandava, M.D., Ph.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-5971

Email:

Journal Publications (Selected out of 23)

  • Sheth KN, Kimberly WT, Elm JJ, Kent TA, Mandava P, Yoo AJ, et al. Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke. 2014;45(1):281-3. [View journal article]
  • Mandava P, Krumpelman CS, Shah JN, White DL, Kent TA. Quantification of errors in ordinal outcome scales using Shannon entropy: effect on sample size calculations. PLoS One. 2013;8(7):e67754. [View journal article]
  • Mandava P, Murthy SB, Munoz M, McGuire D, Simon RP, Alexandrov AV, et al. Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex. Stroke. 2013;44(6):1525-31. [View journal article]
  • Mishra NK, Mandava P, Chen C, Grotta J, Lees KR, Kent TA. Influence of racial differences on outcomes after thrombolytic therapy in acute ischemic stroke. Int J Stroke. 2013;:. [View journal article]
  • Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, et al. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol. 2012;72(5):799-806. [View journal article]
  • Mandava P, Dalmeida W, Anderson JA, Thiagarajan P, Fabian RH, Weir RU, et al. A pilot trial of low-dose intravenous abciximab and unfractionated heparin for acute ischemic stroke: Translating GP IIb/IIIa receptor inhibition to clinical practice. Transl Stroke Res. 2010;1(3):170-7. [View journal article]
  • Mandava P, Kalkonde YV, Rochat RH, Kent TA. A matching algorithm to address imbalances in study populations: application to the national institute of neurological diseases and stroke recombinant tissue plasminogen activator acute stroke trial. Stroke. 2010;41(4):765-70. [View journal article]
  • Mandava P, Kent TA. A method to determine stroke trial success using multidimensional pooled control functions. Stroke. 2009;40(5):1803-10. [View journal article]
  • Mandava P, Kent TA. Percutaneous clot removal in acute ischemic stroke. Arch Neurol. 2009;66(2):283-4; author reply 284. [View journal article]
  • Mandava P, Suarez JI, Kent TA. Intravenous rt-PA versus endovascular therapy for acute ischemic stroke. Curr Atheroscler Rep. 2008;10(4):332-8. [View journal article]

Book Chapters and Other Publications

  • Mandava P, Krumpelman CS, Murthy SB, Kent TA. A critical review of stroke trial analytical methodology: outcome measures, study design, and correction for imbalances. In: Lapchack PA, Zhang JH, editors. Translational stroke research: From target selection to clinical trials. New York: Springer; 2012. p. 833-862.
  • Mandava P, Kent TA. Metabolic disease and stroke: Fabry's disease. In: Lorenzo NY, Lutsep H, editors. eMedicine online neurology reference textbook. eMedicine, Inc.; 2003. Available from: http://www.emedicine.com/NEURO/topic579.htm. [View electronic article]
  • Mandava P, Kent TA. Metabolic disease and stroke: homocysteinuria/homocysteinemia. In: Lorenzo NY, Lutsep H, editors. eMedicine online neurology reference textbook. eMedicine, Inc.; 2003. Available from: http://www.emedicine.com/NEURO/topic578.htm. [View electronic article]
  • Mandava P, Kent TA. Metabolic disease and stroke: hypoglycemia/hyperglycemia. In: Lorenzo NY, Lutsep H, editors. eMedicine online neurology reference textbook. eMedicine, Inc.; 2003. Available from: http://www.emedicine.com/NEURO/topic581.htm. [View electronic article]
  • Mandava P, Kent TA. Metabolic disease and stroke: MELAS. In: Lorenzo NY, Lutsep H, editors. eMedicine online neurology reference textbook. eMedicine, Inc.; 2003. Available from: http://www.emedicine.com/NEURO/topic580.htm. [View electronic article]
  • Mandava P, Kent TA. Metabolic disease and stroke: methylmalonic acidemia. In: Lorenzo NY, Lutsep H, editors. eMedicine online neurology reference textbook. eMedicine, Inc.; 2003. Available from: http://www.emedicine.com/NEURO/topic576.htm. [View electronic article]
  • Mandava P, Kent TA. Metabolic disease and stroke: proprionic acidemia. In: Lorenzo NY, Lutsep H, editors. eMedicine online neurology reference textbook. eMedicine, Inc.; 2003. Available from: http://www.emedicine.com/NEURO/topic577.htm. [View electronic article]

Poster and Platform Presentations (Selected out of 33)

  • Barreto AD, Mandava P, Guerrero W, Shen L, Grotta JC, Kent TA. Combination argatroban and TPA for acute ischemic stroke: A matched case-control analysis. Stroke. 2014;45:AWP52.
  • Mandava P, Shah SD, Sarma AK, Dalmeida D, Kent TA. A pooled analysis indicates the promise and pitfalls of improving upon intravenous rt-PA for ischemic stroke. Stroke. 2014;45:AWP60.
  • Mandava P, Murthy SB, Dalmeida W, Hannawi Y, Wu EY, Kent TA. Generation of a pooled outcome model for traumatic brain injury to use for prediction of potential trial success. Presented at the Neurocritical Care Society (NCS), 11th Annual Meeting in Philadelphia, Penn. (Oct. 1-4, 2013).
  • Shah S, Mandava P, Sarma AK, Kent TA. A pooled analysis identifies the potential to improve upon intravenous rt-PA. Presented at the American Neurological Association (ANA), 138th Annual Meeting in New Orleans, La. (Oct. 13-15, 2013). [Oral Presentation] [View poster]
  • Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al. Outcomes after tPA in African American women with explicit consideration of baseline factors. Stroke. 2013;44(2_MeetingAbstracts):ATP62.
  • Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al. Outcomes after tPA in African American women with explicit consideration of baseline factors. Stroke. 2013;44:ATP62.
  • Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al. Extending the time window with low dose IV abciximab in acute non-lacunar stroke. Stroke. 2013;44(2_MeetingAbstracts):AWP68.
  • Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al. Extending the time window with low dose IV abciximab in acute non-lacunar stroke. Stroke. 2013;44:AWP68.
  • Mandava P, Shah S, Murthy SB, Kent TA. Low dose IV Abciximab for acute ischemic stroke patients ineligible for IV rt-PA. Neurocrit Care. 2012;17:S5. [Platform Presentation]
  • Krumpelman CS, Mandava P, Kent TA. Error rate estimates for the modified Rankin Score "Shift Analysis" using information theory modeling. Stroke. 2012;43(2_MeetingAbstracts) Suppl 1:A2372.

E-mail this page to a friend